Cardiac and Vascular Group
$8.8B
Strengthened by Our Breadth
Restorative Therapies Group $6.5B
Cardiac rhythm disease management
Structural heart
CoronarySurgical technologies
Neuromodulation
Spine
EndovascularDiabetes Group
$1.7B
FY2014 Revenue by Business
$17 Billion
Transforming to Meet Changing Needs
Therapy innovation Globalization Economic value
Medtronic strategies
Growingchronic disease
Broadening stakeholders
Rising cost and healthcare reform
Universal healthcare needs Improved clinical
outcomesExpanded
accessOptimized cost and efficiency
Market dynamics
Applying Core Technologies to Advance Medical Therapy
Electrical stimulation
Targeted drug and biologics delivery
Implantable structural devices
Surgical navigation and imaging
Powered and advanced energy instruments
Patient and device management
Diabetes
Neurological
Spinal and orthopedic
Ear, nose and throat
Structural heart
Urological, urogynecological and gastroenterological
Endovascular
Coronary
Cardiac rhythm
Severe spasticityParkinson’s disease Essential tremor Dystonia*Hydrocephalus Obsessive-compulsive disorder* Brain tumors and lesions Chronic pain Subdural hematomas Cranial trauma
Cervical degenerative disc disease Scoliosis Degenerative disc disease Spinal fracture Lumbar spinal stenosis Tibial fractures Orthopedic trauma
Sinus diseases Thyroid conditions Otologic disorders Sleep-disordered breathing Pediatric conditionsMénière’s disease
Heart valve disease Congenital heart disease
Overactive bladder and urinary retention Nausea and vomiting associated with gastroparesis* Fecal incontinence
Peripheral vascular disease Aortic aneurysms
Coronary artery disease
Atrial fibrillation Slow heart rates (bradycardia) Fast heart rates (tachycardia) Heart failure Asymptomatic heart rates
Alleviating Chronic Conditions
* Humanitarian device in the United States – the effectiveness for this use has not been demonstrated as of FY14. As of FY14
Delivering Innovative Solutions Around the World
Latin America Middle East / Africa
Central / Eastern Europe
Greater China
United States
Asia Pacific
Western Europe / Canada South Asia
international sales 46% countriescountries140+locationslocations260+
strategic regionsstrategic regions9
Japan
Leading the Way
lives improved
350+ clinical trials
40+medical conditions
27,000+ patents
5,600scientists &
engineers
$67Mtotal charitable
contributions
49,000+ employees
$17Brevenue
another life is improved
Every seconds3
10M+
Top Related